Loading asset research
LENZ Therapeutics Inc. Common Stock
LENZNasdaq · USD · StocksQuote as of · Exchange session not verified$4.53
-4.13%
Today
LENZ
Loading 1D prices…
Market cap
$142M
Volume
978K
52w high
$50.4052w low
$4.50Company profile
LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Solana Beach, CA, United States
Employees
152
Fiscal year end
1231
CIK
1815776
Session & valuation
Open$4.71
Previous close$4.72
Day high$4.77
Day low$4.50
30-day avg. volume737.6K
Outstanding shares31.4M
Diluted EPS-$2.85
Latest annual period
P/E (trailing)-1.59
P/E (forward)-1.47
Price / book0.65
Beta1.63
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TNYATenaya Therapeutics Inc. Common Stock | $143.5M | $0.00 | — | -$0.59 | -1.29% | Buy |
| CRBUCaribou Biosciences Inc. Common Stock | $136.2M | $11.2M | -1327.40% | -$1.59 | -6.57% | Buy |
| HUMAHumacyte Inc. Common Stock | $157.7M | $2M | -2003.59% | -$0.26 | +0.25% | Buy |
| OTLKOutlook Therapeutics Inc. Common Stock | $160.7M | $1.4M | -3383.75% | -$0.51 | -0.50% | Buy |
| MOLNMolecular Partners AG American Depositary Shares | $160.9M | — | — | -$1.65 | 0.00% | Buy |